We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Automatic Supervision System Enables Better Patient Outcomes

By HospiMedica International staff writers
Posted on 24 Nov 2008
An innovative contact-free, continuous supervision technology turns the hospital bed into a patient monitor, advancing proactive supervision in the hospital environment.

The EverOn heart and respiration monitor is comprised of a single plate sensing unit equipped with mechanical sensors, and a control unit that integrates signal intake and sampling, signal processing and display, and is capable of various alert outputs. More...
Placed beneath a bed mattress, the sensing unit immediately self-activates whenever the patient is in his bed. Data are continuously filtered, sampled, and analyzed; if desired, the data can be stored and presented later on for offline clinician analysis. The monitor also features a real time connection to a hospital call system and when needed triggers an audible alarm enabling a quick response that may potentially avert medical crises before they materialize. The EverOn monitor is a product of EarlySense (Ramat Gan, Israel), and has been approved by the U.S. Food and Drug Administration (FDA).

"Approximately 80% of patients in the general wards of hospitals are left unattended between rounds, especially at night when the hospital is short staffed. This situation increases the risk of potential safety events and crises for those hospitalized,” said Avner Halperin, CEO of EarlySense. "Continuous supervision of vital signs has the potential to reduce such risks and improve the overall quality of care. The EverOn system is the next natural step in the ongoing efforts of hospitals to improve patient safety and quality of care.”

In a study to evaluate the accuracy of the EverOn system in comparison to standard intensive care unit (ICU) methods, the EverOn's contact-free sensor was placed under the mattresses of more than 40 patient beds. Patients were simultaneously monitored by the ICU's standard of care monitors: electrocardiogram (ECG for) heart rate, and end tidal CO2 and impedance to measure respiration rate. The study showed that when compared to the gold standard, the EverOn measured heart rates accurately over 92% of the time, and respiration rates over 82% of the time. Moreover, EverOn's accuracy in measuring respiration rate was higher than that of the standard monitor measurement, utilizing the thoracic impedance method with standard ECG leads. The study was presented at the European Respiratory Society Conference, held during November 2008 in Berlin (Germany).

Related Links:
EarlySense


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.